October 2, 2026
Buy70/100
conviction
Entry
$1,149.85
Target
$1,322.33
Stop
$1,046.36
50-day MA breakout
Lilly is at the forefront of the GLP-1 drug market, which represents a massive secular growth opportunity.…
Eli Lilly & Co. · Health Care
Lilly's incretin franchise redefined pharma growth, with pipeline depth in obesity, diabetes and neurology. The multiple prices in flawless execution.
The AlphaInsight Score is a proprietary 0–100 composite of momentum, valuation, growth and safety factors. The full research profile — bull/bear cases, financials and the complete technical breakdown — is part of the daily subscriber research.
Daily AI stock picks and automated portfolio insights are available with a Stock Picks Pro subscription.
LLY has appeared in our daily AI research 1 time. Below is the pick history from our daily slates — each entry shows the signal, the entry/target/stop levels published that day, and the conviction score the system assigned. Picks appear here after a two-week subscriber delay. Subscribers receive the complete thesis, risk factors and technical breakdown for every pick.
Lilly is at the forefront of the GLP-1 drug market, which represents a massive secular growth opportunity.…
Subscribers get the complete thesis, risk factors and technical breakdown for LLYand 10 researched ideas every trading day.
Cancel anytime · Secure checkout
Ready-to-paste citation snippets for forums, Reddit, X or your own site.
[LLY stock research — AlphaInsight Score & technical signals](https://alphainsightai.net/stocks/LLY)<a href="https://alphainsightai.net/stocks/LLY">LLY stock research — AlphaInsight Score & technical signals</a>